Dantrolene: A Selective Ryanodine Receptor Antagonist, Protects Against Pentylenetetrazole-Induced Seizure in Mice.
Ryanodine receptor abnormalities has implicated in the generation and maintenance of seizure. Dantrolene, a selective ryanodine receptor antagonist, may be a potential drug for the prevention of seizure. Therefore, we aimed to clarify the protective effects of dantrolene against pentylenetetrazole seizure in mice. Male albino mice were received an intra-peritoneal injection of pentylenetetrazole (80 mg/kg) in seven separate groups (n=8). We used dantrolene (10,20 and 40 mg/kg), caffeine (200 mg/kg), dantrolene (40 mg/kg) + caffeine (200 mg/kg), diazepam (5 mg/kg as a positive control) and vehicle 30 minutes before the injection of pentylenetetrazole. Then, we registered the latency time of the first seizure, the severity of seizures and the incidence of seizure and death. Kruskal-Wallis test followed by Mann-Whitney and Fisher's exact test were used to analyze the data. Dantrolene (10,20 and 40 mg/kg) significantly increased the latency time for the first seizure. Furthermore, dantrolene (20 and 40 mg/kg, but not 10 mg/kg) attenuated the severity of seizures in comparison to the vehicle group. Moreover, dantrolene only at the dose of 40 mg/kg prevented from tonic-clonic seizure and death in comparison to the vehicle group. In contrast, the addition of caffeine abolished the protective effects of dantrolene on the tonic-clonic seizure/death and inhibited the beneficial effects of dantrolene on the severity of pentylenetetrazol seizures. The acute dantrolene administration produced an anticonvulsant effect in the pentylenetetrazole-induced seizure. Moreover, caffeine prevented from dantrolene anticonvulsant effects. These results may imply about ryanodine receptors and intracellular calcium roles in the generation and control of pentylenetetrazole seizure.
Department of Pharmacology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran. AND Department of Medicine, Shiraz Neurosciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mojtaba
M
Keshavarz
Department of Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Morteza
M
Fotouhi
Department of Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Alireza
A
Rasti
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D003620:Dantrolene / Q000494:pharmacology*; D003975:Diazepam / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole / Q000633:toxicity; D019837:Ryanodine Receptor Calcium Release Channel / Q000187:drug effects; D012640:Seizures / Q000517:prevention & control*
D000927:Anticonvulsants; D019837:Ryanodine Receptor Calcium Release Channel; D003620:Dantrolene; D003975:Diazepam; D010433:Pentylenetetrazole
Caffeine; Dantrolene; Pentylenetetrazole; Ryanodine receptors; Seizure